当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2019年第12期
编号:13437276
PDCA对提高手外科患者活动功能的效果分析(2)
http://www.100md.com 2019年12月1日 《特别健康·下半月》 2019年第12期
     [3] Young MK,Sungchan P,June K,etal,Role of prostate volumein the early detection of prostatecancer in a cohort with slowly increasing prostate specific antigen,Yonsei Med J,2013,54(5):1202-1206.

    [4] Petrillo A, Fusco R, Setola S V, et al.Multiparametric MRI for prostate cancerdetection: performance in patients with prostate-specific antigen values between 2.5 and 10 ng/mL[J].J Magn Reson Imaging.2014, 39(5):1206-1212.

    [5] Thompson IM,Pauler DK,Goodman PJ,et al. Prevalenceof prostate cancer among men with a prostate-specificantigen level
    [6] 吳登龙,金重睿,张 炯,等. 血清游离前列腺特异性抗原百分率在前列腺癌诊断盲区的价值评价[J].上海医学,2002(Z1):39-40.

    [7] 华立新,吴宏飞,程双管. 前列腺特异性抗原小于 4 ng/ml前列腺癌的临床特点[J].南京医科大学学报(自然科学版),2001,21(4):331-332.

    [8] Hudson MA,Bahnson RR,Catalona WJ. Clinical use ofprostate specific antigen in patients with prostate cancer[J].J Urol,1989,142(4):1011-1017.

    [9] Gaspar M J,Arribas I,Hontoria JM,et al. Usefulness of thepercentage of free prostatic specific antigen in the differ-ential diagnosis between benign prostatic hyperplasia andprostate cancer[J].Med Clin (Barc),2000,115 (9):332-336., http://www.100md.com(杜鹃)
上一页1 2